Roivant Sciences Q1 EPS $(0.38) Misses $(0.30) Estimate, Sales $21.62M Miss $29.36M Estimate
Portfolio Pulse from Benzinga Newsdesk
Roivant Sciences (NASDAQ:ROIV) reported Q1 losses of $(0.38) per share, missing the analyst consensus estimate of $(0.30) by 26.67%. The company also reported quarterly sales of $21.62 million, missing the analyst consensus estimate of $29.36 million by 26.35%. However, this is a 400.67% increase over sales of $4.32 million the same period last year.
August 14, 2023 | 11:03 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Roivant Sciences reported Q1 losses and sales that missed analyst estimates. However, sales increased by 400.67% compared to the same period last year.
Roivant Sciences reported lower than expected earnings and sales for Q1, which could negatively impact the stock price. However, the significant increase in sales compared to the same period last year could mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100